4.0 Article

Discovery of novel 4-methylpiperidinyl benzamide derivatives as 5-HT4 receptor agonist for the treatment of gastrointestinal disorders

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome

L. Ohman et al.

DIGESTIVE AND LIVER DISEASE (2007)

Review Gastroenterology & Hepatology

The serotonin signaling system: From basic understanding to drug development-for functional GI disorders

Michael D. Gershon et al.

GASTROENTEROLOGY (2007)

Article Medicine, General & Internal

BMJ learning - Irritable bowel syndrome: diagnosis and management

A Agrawal et al.

BMJ-BRITISH MEDICAL JOURNAL (2006)

Article Pharmacology & Pharmacy

Effect of ginseng saponins on a rat visceral hypersensitivity model

JH Kim et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)

Review Pharmacology & Pharmacy

Rationale for using serotonergic agents to treat irritable bowel syndrome

DE Baker

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2005)

Article Pharmacology & Pharmacy

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

DT Beattie et al.

BRITISH JOURNAL OF PHARMACOLOGY (2004)

Article Pharmacology & Pharmacy

Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays

JY Jin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Article Biochemistry & Molecular Biology

Design and synthesis of orally active benzamide derivatives as potent serotonin 4 receptor agonist

S Sonda et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2003)